PriceTargets.com logo

Molina Healthcare - MOH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $365.71
  • Forecasted Upside: 12.00 %
  • Number of Analysts: 12
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$326.53 As of 11/28/2022 01:00 AM ET
▼ -0.55 (-0.17%)

This chart shows the closing price for MOH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Molina Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MOH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MOH

Analyst Price Target is $365.71
▲ +12.00% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Molina Healthcare in the last 3 months. The average price target is $365.71, with a high forecast of $420.00 and a low forecast of $310.00. The average price target represents a 12.00% upside from the last price of $326.53.

This chart shows the closing price for MOH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 12 investment analysts is to buy stock in Molina Healthcare. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
6/6/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
9/4/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
12/3/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
3/3/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
6/1/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
8/30/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
10/29/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
11/28/2022

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/7/2022CowenBoost Target$371.00 ➝ $380.00Low
11/7/2022CowenBoost Target$371.00 ➝ $380.00Low
11/1/2022Deutsche Bank AktiengesellschaftBoost TargetHold$315.00 ➝ $355.00Low
10/28/2022BarclaysBoost TargetOverweight$380.00 ➝ $400.00Low
10/28/2022Truist FinancialBoost TargetBuy$390.00 ➝ $420.00Low
10/27/2022Credit Suisse GroupBoost TargetOutperform$350.00 ➝ $410.00Low
10/3/2022JPMorgan Chase & Co.Initiated CoverageOverweight$360.00Low
8/26/2022Wells Fargo & CompanyBoost TargetUnderweight$307.00 ➝ $345.00Low
8/9/2022CowenBoost Target$371.00Low
8/1/2022Deutsche Bank AktiengesellschaftBoost Target$311.00 ➝ $315.00Low
7/19/2022Credit Suisse GroupSet Target$321.00Low
6/16/2022Loop CapitalInitiated CoverageHold$310.00Medium
5/26/2022Bank of AmericaDowngradeBuy ➝ Underperform$355.00 ➝ $335.00High
5/25/2022Wells Fargo & CompanyLower TargetUnderweight$308.00 ➝ $301.00Low
5/2/2022CowenBoost Target$356.00 ➝ $366.00Low
5/2/2022CowenBoost Target$356.00 ➝ $366.00Medium
5/2/2022Deutsche Bank AktiengesellschaftBoost Target$308.00 ➝ $311.00Medium
4/7/2022Truist FinancialBoost Target$360.00 ➝ $390.00Medium
2/22/2022Morgan StanleyLower TargetOverweight$397.00 ➝ $365.00High
2/14/2022BMO Capital MarketsBoost TargetOutperform$365.00 ➝ $380.00Low
2/11/2022Deutsche Bank AktiengesellschaftBoost Target$304.00 ➝ $308.00Low
2/11/2022MizuhoBoost TargetBuy$330.00 ➝ $345.00Low
1/5/2022Truist FinancialBoost Target$345.00 ➝ $360.00High
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$335.00High
11/22/2021Deutsche Bank AktiengesellschaftInitiated CoverageHoldMedium
11/2/2021Wells Fargo & CompanyBoost TargetUnderweight$256.00 ➝ $281.00Low
11/1/2021MizuhoBoost TargetBuy$305.00 ➝ $330.00Low
10/29/2021Morgan StanleyBoost TargetOverweight$316.00 ➝ $397.00High
10/29/2021StephensBoost TargetEqual Weight$280.00 ➝ $300.00Medium
10/29/2021Credit Suisse GroupBoost TargetOutperform$318.00 ➝ $330.00Low
10/29/2021BarclaysBoost TargetOverweight$310.00 ➝ $340.00Low
9/20/2021Morgan StanleyBoost TargetOverweight$296.00 ➝ $316.00Low
9/20/2021Truist FinancialBoost TargetBuy$300.00 ➝ $330.00Low
9/20/2021Credit Suisse GroupBoost TargetOutperform$280.00 ➝ $318.00Low
9/20/2021StephensBoost TargetEqual Weight$260.00 ➝ $280.00Low
9/20/2021MizuhoBoost TargetBuy$284.00 ➝ $305.00Low
9/9/2021CowenInitiated CoverageOutperform$336.00High
8/31/2021Morgan StanleyLower TargetOverweight$297.00 ➝ $296.00Medium
8/3/2021Wells Fargo & CompanyBoost TargetUnderweight$253.00 ➝ $256.00Medium
7/30/2021BMO Capital MarketsBoost TargetOutperform$300.00 ➝ $315.00High
7/30/2021MizuhoBoost TargetBuy$273.00 ➝ $284.00High
7/9/2021Seaport Res PtnReiterated RatingNeutralLow
6/3/2021Morgan StanleyBoost TargetOverweight$244.00 ➝ $297.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageUnderweight$253.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageUnderweight$253.00Medium
4/30/2021MizuhoBoost TargetBuy$245.00 ➝ $273.00Low
4/14/2021Truist FinancialBoost TargetBuy$260.00 ➝ $290.00Low
3/30/2021Credit Suisse GroupInitiated CoverageOutperform$260.00Low
3/15/2021MizuhoInitiated CoverageBuy$245.00N/A
3/9/2021MizuhoInitiated CoverageBuy$245.00High
2/19/2021BarclaysReiterated RatingOverweight$260.00Medium
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutral$217.00Low
1/5/2021Truist FinancialBoost Target$240.00 ➝ $260.00N/A
11/11/2020Piper SandlerBoost TargetOverweight$213.00 ➝ $266.00Low
10/30/2020SVB LeerinkBoost TargetOutperform$228.00 ➝ $255.00Low
9/22/2020StephensDowngradeOverweight ➝ Equal WeightHigh
9/1/2020SVB LeerinkBoost TargetOutperform$226.00 ➝ $228.00Low
8/3/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$188.00 ➝ $194.00Medium
8/3/2020SVB LeerinkBoost TargetOutperform$220.00 ➝ $226.00Low
7/1/2020SVB LeerinkInitiated CoverageOutperform$220.00Low
6/16/2020CowenUpgradeMarket Perform ➝ Outperform$200.00 ➝ $210.00Medium
6/1/2020SunTrust BanksBoost TargetPositive ➝ Buy$210.00 ➝ $230.00Low
6/1/2020StephensBoost TargetOverweight$202.00 ➝ $215.00Low
5/15/2020Morgan StanleyBoost TargetOverweight$175.00 ➝ $229.00High
5/4/2020CfraUpgradeHold ➝ Buy$141.00 ➝ $191.00High
5/4/2020SunTrust BanksBoost TargetBuy$185.00 ➝ $210.00High
5/4/2020Piper SandlerBoost TargetOverweight$194.00 ➝ $208.00High
5/4/2020Deutsche Bank AktiengesellschaftLower TargetBuy$206.00 ➝ $188.00Medium
4/14/2020StephensUpgradeEqual Weight ➝ Overweight$145.00 ➝ $188.00Medium
4/13/2020SunTrust BanksBoost TargetBuy$165.00 ➝ $185.00Medium
4/13/2020Morgan StanleyBoost TargetOverweight$165.00 ➝ $175.00Low
4/8/2020CitigroupUpgradeUnderperform ➝ Average$125.00 ➝ $171.00High
4/8/2020Bank of AmericaUpgradeUnderperform ➝ Buy$125.00 ➝ $171.00High
3/27/2020Morgan StanleyBoost TargetOverweight$153.00 ➝ $165.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$156.00 ➝ $206.00Low
2/12/2020BMO Capital MarketsBoost TargetOutperform$152.00 ➝ $170.00Medium
2/11/2020CfraBoost TargetHold$128.00 ➝ $141.00Medium
1/7/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$145.00 ➝ $150.00Medium
12/20/2019JPMorgan Chase & Co.Boost TargetOverweight$150.00 ➝ $152.00High
10/30/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$133.00 ➝ $120.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$145.00High
8/23/2019Morgan StanleyLower TargetOverweight$184.00 ➝ $172.00High
8/7/2019StephensSet TargetHold$150.00Low
7/31/2019Bank of AmericaReiterated RatingUnderperform ➝ Underperform$132.00 ➝ $140.00High
7/12/2019Morgan StanleyBoost TargetOverweight$178.00 ➝ $184.00Low
6/3/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$154.00 ➝ $200.00Low
5/31/2019BarclaysBoost TargetEqual Weight$140.00 ➝ $149.00High
5/31/2019Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$177.00High
5/5/2019BarclaysReiterated RatingHold$140.00Medium
4/30/2019Bank of AmericaReiterated RatingUnderperform ➝ Underperform$129.00 ➝ $132.00High
4/17/2019BarclaysLower TargetEqual Weight ➝ Equal Weight$140.00 ➝ $130.00High
2/28/2019CowenInitiated CoverageMarket PerformHigh
2/13/2019Morgan StanleyBoost TargetOverweight ➝ Overweight$180.00 ➝ $192.00Medium
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$144.00Low
1/8/2019Mitsubishi UFJ Financial GroupUpgradeNeutral ➝ OverweightLow
1/8/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$127.00 ➝ $150.00High
1/3/2019Wolfe ResearchDowngradeOutperform ➝ Market PerformHigh
11/13/2018Jefferies Financial GroupUpgradeHold ➝ Buy$152.00 ➝ $169.00Medium
10/18/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$178.00 ➝ $184.00Medium
10/12/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$152.00Low
10/9/2018Evercore ISIInitiated CoverageIn-line ➝ In-Line$158.00High
9/26/2018Piper Jaffray CompaniesBoost TargetOverweight$165.00Medium
9/5/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$132.00 ➝ $178.00Low
8/2/2018BarclaysBoost TargetEqual Weight ➝ Equal Weight$105.00 ➝ $125.00High
8/2/2018Wells Fargo & CompanyBoost TargetMarket Perform$92.00 ➝ $120.00High
8/2/2018SunTrust BanksBoost TargetBuy$140.00High
8/2/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$108.00 ➝ $132.00High
8/2/2018Piper Jaffray CompaniesReiterated RatingOverweight$134.00High
8/1/2018Bank of AmericaBoost TargetUnderperform ➝ Underperform$94.00 ➝ $110.00Low
7/24/2018Bank of AmericaBoost TargetUnderperform ➝ Underperform$91.00 ➝ $94.00Low
7/23/2018BarclaysInitiated CoverageEqual Weight$105.00Low
7/13/2018Morgan StanleyBoost TargetOverweight$100.00 ➝ $108.00Medium
7/10/2018SunTrust BanksBoost TargetBuy$120.00Low
6/28/2018Wells Fargo & CompanyBoost TargetMarket Perform ➝ Market Perform$90.00 ➝ $92.00Low
6/28/2018Jefferies Financial GroupUpgradeHold ➝ BuyLow
6/27/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
6/22/2018Jefferies Financial GroupUpgradeHold ➝ Buy$74.00High
6/19/2018BMO Capital MarketsBoost TargetMarket Perform$105.00Low
6/1/2018BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$85.00 ➝ $94.00Medium
5/1/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$91.00 ➝ $100.00Medium
3/28/2018SVB LeerinkBoost TargetOutperform$100.00 ➝ $110.00Low
3/20/2018Piper Jaffray CompaniesBoost TargetOverweight$92.00Medium
2/15/2018JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$103.00 ➝ $91.00Low
2/14/2018BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$98.00 ➝ $85.00Low
2/14/2018Morgan StanleyLower TargetOverweight ➝ Overweight$94.00 ➝ $91.00Medium
2/14/2018Jefferies Financial GroupReiterated RatingHold$80.00Medium
2/7/2018Morgan StanleyLower TargetOverweight ➝ Overweight$97.00 ➝ $94.00Medium
1/16/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
1/9/2018SVB LeerinkBoost TargetOutperform$100.00 ➝ $105.00Medium
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$83.00Medium
12/8/2017Raymond JamesReiterated RatingHoldLow
(Data available from 11/28/2017 forward)

News Sentiment Rating

0.68 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/2/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/1/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/1/2022
  • 14 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/31/2022
  • 6 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
8/30/2022
  • 8 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2022
  • 11 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
10/29/2022
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2022

Current Sentiment

  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Molina Healthcare logo
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Today's Range

Now: $326.53
Low: $324.91
High: $329.18

50 Day Range

MA: $339.17
Low: $312.03
High: $369.23

52 Week Range

Now: $326.53
Low: $249.78
High: $374.00

Volume

560,541 shs

Average Volume

488,097 shs

Market Capitalization

$19.07 billion

P/E Ratio

22.79

Dividend Yield

N/A

Beta

0.81

Frequently Asked Questions

What sell-side analysts currently cover shares of Molina Healthcare?

The following Wall Street research analysts have issued research reports on Molina Healthcare in the last year: Bank of America Co., Barclays PLC, BMO Capital Markets, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, StockNews.com, The Goldman Sachs Group, Inc., Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for MOH.

What is the current price target for Molina Healthcare?

14 Wall Street analysts have set twelve-month price targets for Molina Healthcare in the last year. Their average twelve-month price target is $365.71, suggesting a possible upside of 12.0%. Truist Financial Co. has the highest price target set, predicting MOH will reach $420.00 in the next twelve months. Loop Capital has the lowest price target set, forecasting a price of $310.00 for Molina Healthcare in the next year.
View the latest price targets for MOH.

What is the current consensus analyst rating for Molina Healthcare?

Molina Healthcare currently has 2 sell ratings, 2 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MOH will outperform the market and that investors should add to their positions of Molina Healthcare.
View the latest ratings for MOH.

What other companies compete with Molina Healthcare?

Other companies that are similar to Molina Healthcare include Centene, Humana, BeiGene, Hologic and BioMarin Pharmaceutical. Learn More about companies similar to Molina Healthcare.

How do I contact Molina Healthcare's investor relations team?

Molina Healthcare's physical mailing address is 200 OCEANGATE SUITE 100, LONG BEACH CA, 90802. The company's listed phone number is (562) 435-3666 and its investor relations email address is [email protected] The official website for Molina Healthcare is www.molinahealthcare.com. Learn More about contacing Molina Healthcare investor relations.